Heather Hinton

2.5k total citations
33 papers, 1.6k citations indexed

About

Heather Hinton is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Heather Hinton has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Heather Hinton's work include T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (12 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Heather Hinton is often cited by papers focused on T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (12 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Heather Hinton collaborates with scholars based in Switzerland, United Kingdom and United States. Heather Hinton's co-authors include Martin F. Bachmann, Andrea Jegerlehner, Juliana Bessa, Doreen A. Cantrell, Melanie J. Welham, Manfred Köpf, Patrik Maurer, Dario R. Alessi, Nicole Schmitz and Katrin Schwarz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Heather Hinton

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather Hinton Switzerland	19	781	721	316	214	142	33	1.6k
Sidorenko Sp Ukraine	19	1.3k 1.6×	743 1.0×	359 1.1×	222 1.0×	133 0.9×	45	2.0k
Michael Hahne France	11	1.1k 1.3×	652 0.9×	232 0.7×	260 1.2×	164 1.2×	12	1.7k
Guangming Huang United States	21	1.5k 1.9×	594 0.8×	293 0.9×	236 1.1×	162 1.1×	31	2.2k
Yasumichi Hitoshi Japan	22	1.1k 1.4×	814 1.1×	421 1.3×	116 0.5×	103 0.7×	48	2.1k
Paola Fortugno Italy	18	443 0.6×	1.1k 1.6×	358 1.1×	176 0.8×	97 0.7×	42	1.8k
Antoine Alam France	17	853 1.1×	818 1.1×	349 1.1×	240 1.1×	143 1.0×	26	1.7k
Dale R. Taylor United Kingdom	9	892 1.1×	522 0.7×	285 0.9×	144 0.7×	87 0.6×	12	1.6k
Vera Chan Hong Kong	20	1.4k 1.8×	540 0.7×	318 1.0×	140 0.7×	172 1.2×	40	2.2k
Gábor Pál Hungary	25	761 1.0×	736 1.0×	193 0.6×	124 0.6×	52 0.4×	62	1.9k
Jeff D. Colbert United States	18	944 1.2×	804 1.1×	526 1.7×	167 0.8×	240 1.7×	20	1.8k

Countries citing papers authored by Heather Hinton

Since Specialization

Citations

This map shows the geographic impact of Heather Hinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Hinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Hinton more than expected).

Fields of papers citing papers by Heather Hinton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Hinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Hinton. The network helps show where Heather Hinton may publish in the future.

Co-authorship network of co-authors of Heather Hinton

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Hinton. A scholar is included among the top collaborators of Heather Hinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Hinton. Heather Hinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamois, Candice, Koorosh Korfi, Sylvia Herter, et al.. (2024). Integrated Quantitative Clinical Pharmacology Analysis Identifies Optimal Englumafusp Alfa Dose Range for Proof-of-Concept Study with Glofitamab in Second-Line Large B-Cell Lymphoma Patients. Blood. 144(Supplement 1). 4180–4180.

Dent, Rebecca, Sung‐Bae Kim, Mafalda Oliveira, et al.. (2024). Ipatasertib plus Paclitaxel for Patients with PIK3CA / AKT1 / PTEN -Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial. Clinical Cancer Research. 30(19). 4329–4338. 9 indexed citations

Kotani, Naoki, Justin Wilkins, Janet R. Wade, et al.. (2022). Characterization of exposure–response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study. Cancer Chemotherapy and Pharmacology. 90(6). 511–521. 4 indexed citations

Turner, Nicholas C., Rebecca Dent, Joyce O’Shaughnessy, et al.. (2021). Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial. Breast Cancer Research and Treatment. 191(3). 565–576. 64 indexed citations

Frances, Nicolas, Marina Bacac, Katharine Bray‐French, et al.. (2021). Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab. Journal of Pharmaceutical Sciences. 111(4). 1208–1218. 18 indexed citations

Turner, Nicholas C., Rebecca Dent, Joyce O’Shaughnessy, et al.. (2020). 283MO Ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN-altered hormone receptor-positive (HR+) HER2-negative advanced breast cancer (aBC): Primary results from Cohort B of the IPATunity130 randomised phase III trial. Annals of Oncology. 31. S354–S355. 10 indexed citations

Vessillier, Sandrine, Madeline Fort, Heather Hinton, et al.. (2020). Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms – Report of an international collaborative study. SHILAP Revista de lepidopterología. 2(4). 100042–100042. 9 indexed citations

Peterson, Laurence B., Sarah Howlett, Marcin Ł. Pękalski, et al.. (2018). A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. Journal of Autoimmunity. 95. 1–14. 104 indexed citations

Bailey, Lucy, Laura Moreno, Tobias Manigold, et al.. (2012). A simple whole blood bioassay detects cytokine responses to anti-CD28SA and anti-CD52 antibodies. Journal of Pharmacological and Toxicological Methods. 68(2). 231–239. 13 indexed citations

10.

Bessa, Juliana, Andrea Jegerlehner, Heather Hinton, et al.. (2009). Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses. The Journal of Immunology. 183(6). 3788–3799. 62 indexed citations

11.

Hinton, Heather, Monika Bauer, Simone Muntwiler, et al.. (2009). Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles. The Journal of Immunology. 182(10). 6261–6266. 14 indexed citations

12.

Gatto, Dominique, Stephen W. Martin, Juliana Bessa, et al.. (2007). Regulation of Memory Antibody Levels: The Role of Persisting Antigen versus Plasma Cell Life Span. The Journal of Immunology. 178(1). 67–76. 48 indexed citations

13.

Jegerlehner, Andrea, Patrik Maurer, Juliana Bessa, et al.. (2007). TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a. The Journal of Immunology. 178(4). 2415–2420. 223 indexed citations

14.

Hinton, Heather, Andrea Jegerlehner, & Martin F. Bachmann. (2007). Pattern Recognition by B Cells: The Role of Antigen Repetitiveness Versus Toll-Like Receptors. Current topics in microbiology and immunology. 319. 1–15. 44 indexed citations

15.

Kelly, April, David K. Finlay, Heather Hinton, et al.. (2007). Notch-induced T cell development requires phosphoinositide-dependent kinase 1. The EMBO Journal. 26(14). 3441–3450. 111 indexed citations

16.

Bessa, Juliana, Nicole Schmitz, Heather Hinton, et al.. (2007). Efficient induction of mucosal and systemic immune responses by virus‐like particles administered intranasally: implications for vaccine design. European Journal of Immunology. 38(1). 114–126. 125 indexed citations

17.

Hinton, Heather, Rosemary G. Clarke, & Doreen A. Cantrell. (2006). Antigen receptor regulation of phosphoinositide‐dependent kinase 1 pathways during thymocyte development. FEBS Letters. 580(25). 5845–5850. 12 indexed citations

18.

Kelly, April, Heather Hinton, Rosemary G. Clarke, & Doreen A. Cantrell. (2006). Phosphoinositide‐dependent kinase l (PDK1) haplo‐insufficiency inhibits production of alpha/beta (α/β) but not gamma delta (γ/δ) T lymphocytes. FEBS Letters. 580(8). 2135–2140. 11 indexed citations

19.

Hinton, Heather, et al.. (1999). Dissociation of Apoptosis from Proliferation, Protein Kinase B Activation, and BAD Phosphorylation in Interleukin-3-mediated Phosphoinositide 3-Kinase Signaling. Journal of Biological Chemistry. 274(15). 10633–10640. 93 indexed citations

20.

Hinton, Heather & Melanie J. Welham. (1999). Cytokine-Induced Protein Kinase B Activation and Bad Phosphorylation Do Not Correlate with Cell Survival of Hemopoietic Cells. The Journal of Immunology. 162(12). 7002–7009. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact